Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia]Tiejun Qin, Zefeng Xu, Yue Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 16, 2016
[The assessment of symptomatic burden among Ph/BCR- ABL negative myeloproliferative neoplasm patients]Junqing Xu, Zefeng Xu, Jingya Wang, et al.
Leukemia Research|September 4, 2014
Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosisJingya Wang, Junqing Xu, Robert Peter Gale, et al.
American Journal of Hematology|July 22, 2014
Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndromeRuixian Xing, Chengwen Li, Robert Peter Gale, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Clinical and laboratory characteristics in patients of myelodysplastic syndrome with PNH clones]Yan Li, Tiejun Qin, Zefeng Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[A study of prognostic value of cytogenetics in patients with primary myelofibrosis]Bing Li, Junqing Xu, Zefeng Xu, et al.
American Journal of Hematology|August 19, 2014
Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosisBing Li, Junqing Xu, Chengwen Li, et al.
Pageof 8